Respifortin

Medicinal product

(Invented) name

Respifortin

Active substance (s)

Acetilcisteinas

Strength

600 mg

Pharmaceutical form

šnypščiosios tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Nereceptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

R05CB01, Acetylcysteine

Marketing authorisation holder

Natur Produkt Zdrovit Sp. z o.o., Lenkija

Date of authorisation

2018-09-27

Date of renewal

2023-06-08

Documents

4269_pakuotes lapelis_2023-06-08.DOCX

4269_Respifortin_perr2023-06-08.DOCX

Stage

Perregistruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

PL/H/0469/001/DC

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Acetilcisteinas	600 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
100197	86306	1086306	talpyklė	N10		Nereceptinis	LT/1/18/4269/001	Tiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2023-06-08	Perregistruotas
2018-09-27	Registruotas